Coverage
-
March 11, 2011
Aventis Pharma SA and Sanofi-Aventis U.S. LLC decided Friday to stop fighting a judgment in favor of Sandoz Inc. in its patent suit over Sandoz's generic version of cancer treatment Taxotere.
1 other articles on this case.
View all »